Exact Sciences Corp.’s recently made public that its President and CEO Conroy Kevin T unloaded Company’s shares for reported $69473.0 on May 01 ’24. In the deal valued at $60.15 per share,1,155 shares were sold. As a result of this transaction, Conroy Kevin T now holds 1,156,191 shares worth roughly $73.24 million.
Then, Cunningham Everett sold 136 shares, generating $8,180 in total proceeds. Upon selling the shares at $60.15, the Chief Commercial Officer now owns 47,042 shares.
Before that, Elliott Jeffrey Thomas sold 136 shares. Exact Sciences Corp. shares valued at $8,180 were divested by the Chief Financial Officer at a price of $60.15 per share. As a result of the transaction, Elliott Jeffrey Thomas now holds 11,795 shares, worth roughly $0.75 million.
The Benchmark Company upgraded its Exact Sciences Corp. [EXAS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Wolfe Research began covering EXAS with “an Outperform” recommendation on December 13, 2023. Piper Sandler revised its rating on October 10, 2023. It rated EXAS as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of EXAS
On Monday, Exact Sciences Corp. [NASDAQ:EXAS] saw its stock jump 2.06% to $63.35. Over the last five days, the stock has gained 7.77%. Exact Sciences Corp. shares have fallen nearly -14.37% since the year began. Nevertheless, the stocks have fallen -3.65% over the past one year. While a 52-week high of $100.77 was reached on 04/02/24, a 52-week low of $56.05 was recorded on 02/28/24. SMA at 50 days reached $63.26, while 200 days put it at $69.00. A total of 2.65 million shares were traded, compared to the trading of 1.59 million shares in the previous session.
Levels Of Support And Resistance For EXAS Stock
The 24-hour chart illustrates a support level at 60.79, which if violated will result in even more drops to 58.22. On the upside, there is a resistance level at 64.90. A further resistance level may holdings at 66.44. The Relative Strength Index (RSI) on the 14-day chart is 50.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.66, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 36.90%. Stochastics %K at 44.39% indicates the stock is a holding.
The most recent change occurred on September 28, 2023 when Bernstein began covering the stock and recommended ‘”an Outperform”‘ rating along with a $83 price target.
